![Su-Jin Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 15 M $ au 30/06/2026
Dr. Su-Jin Lee is a Chief Executive Officer & Director at Aptabio Therapeutics, Inc. He is on the Board of Directors at Aptabio Therapeutics, Inc. He received his undergraduate degree from Chungbuk National University, a graduate degree from Chungbuk National University and a doctorate degree from Ajou University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2025 | 4 894 600 ( 17,42% ) | 15 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| APTABIO THERAPEUTICS INC. | Fondateur | 24/07/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Ajou University
 Ajou University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chungbuk National University
 Chungbuk National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptabio Therapeutics, Inc.
 Aptabio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures anti-cancer and inflammatory fibrotic disease drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
